Predictions
Transgene S.A.
Start price
Target price
Perf. (%)
€2.43
07.11.21
07.11.21
€2.80
07.11.22
07.11.22
-20.58%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.40
01.11.21
01.11.21
€15.00
01.11.22
01.11.22
79.03%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.80
24.10.22
24.10.22
€7.00
24.10.23
24.10.23
18.42%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.70
18.10.22
18.10.22
-
18.10.23
18.10.23
0.78%
29.10.22
29.10.22
Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.54
15.10.22
15.10.22
€2.00
15.10.23
15.10.23
-0.88%
29.10.22
29.10.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Affimed N.V.
Start price
Target price
Perf. (%)
€4.14
26.02.22
26.02.22
-
26.02.23
26.02.23
-59.29%
27.10.22
27.10.22
Could be very worthwhile Investment >20% year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.75
06.10.22
06.10.22
€0.000
06.10.23
06.10.23
-61.11%
24.10.22
24.10.22
Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Virbac S.A.
Start price
Target price
Perf. (%)
€401.50
07.11.21
07.11.21
€385.00
07.11.22
07.11.22
-38.36%
22.10.22
22.10.22
Could be worthwhile Investment >10% per year
Durect Corp.
Start price
Target price
Perf. (%)
€1.03
17.10.21
17.10.21
-
17.10.22
17.10.22
-48.06%
18.10.22
18.10.22
Probably not worthwhile Investment
Athersys Inc.
Start price
Target price
Perf. (%)
€1.87
19.09.22
19.09.22
€3.80
19.09.23
19.09.23
0.19%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.64
19.09.22
19.09.22
€17.00
19.09.23
19.09.23
-34.41%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.41
27.09.22
27.09.22
€11.60
27.09.23
27.09.23
8.69%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€9.36
16.10.21
16.10.21
€20.00
16.10.22
16.10.22
47.44%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.08
18.05.22
18.05.22
-
18.05.23
18.05.23
-3.43%
16.10.22
16.10.22
Risky Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.86
08.10.22
08.10.22
€5.00
08.10.23
08.10.23
9.28%
16.10.22
16.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.12
04.09.22
04.09.22
-
04.09.23
04.09.23
-11.64%
15.10.22
15.10.22
Could be worthwhile Investment >10% per year
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.17
20.09.22
20.09.22
-
20.09.23
20.09.23
-15.38%
15.10.22
15.10.22
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€34.98
27.08.22
27.08.22
€16.00
27.08.23
27.08.23
-38.94%
13.10.22
13.10.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.10
10.10.21
10.10.21
€15.00
10.10.22
10.10.22
-84.33%
11.10.22
11.10.22
Could be worthwhile Investment >10% per year
Some uniques
scPharmaceuticals
Start price
Target price
Perf. (%)
€6.15
29.09.22
29.09.22
€8.00
31.12.24
31.12.24
-23.25%
10.10.22
10.10.22
Could be very worthwhile Investment >20% year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.42
03.10.22
03.10.22
-
03.10.23
03.10.23
-81.66%
07.10.22
07.10.22
Risky Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.38
03.10.22
03.10.22
€7.00
03.10.23
03.10.23
-44.51%
06.10.22
06.10.22
Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.76
30.09.22
30.09.22
-
30.09.23
30.09.23
39.41%
03.10.22
03.10.22
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€1.88
20.09.22
20.09.22
€1.60
20.09.23
20.09.23
-7.46%
03.10.22
03.10.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital